We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 6, 2020

Making health plans more customer-friendly: A tête-à-tête with Abir Sen

Announcements/News
Sophie Madden
&
Chandana Fitzgerald

In our first ever videocast, we talk to Abir Sen, Executive Chairman and Co-Founder of Gravie. Entrepreneurship, consumer empowerment in healthcare decision making, and questioning the status quo are at the heart of this discussion. 

In this podcast, Abir shares his learnings throughout his diverse career, his thoughts on our recently released report on the digital maturity of US Payers, including a discussion on consumer driven healthcare in the US compared to other markets (or lack thereof), why ‘’the key to success is a set of assets that help the consumer be better at health’’, how incumbents are reacting to new players in the health plan space, the impact of COVID-19 on the industry, and why fortune 500 companies don’t actually need Chief Medical Officers unless they are healthcare companies. We also unveil the surprising career Abir would have chosen if he wasn’t doing what he does now. As highlighted in our report that was based on interviews with some of the top US health plans, commercial deals made by payers in digital is key, but showing outcomes and impact from these is crucial, and that is where we may be lagging behind. Some of the work Abir does through his companies aspire to change that dynamic. 

Listen on Spotify


Abir began his career as a consultant in Deloitte but after nine months on the job, and at just twenty-three years old, Abir and some of his colleagues decided to leave Deloitte and set-up their own startup company called Definity Health. Abir quotes the catalyst for this change as being the realisation that nobody else was going to give him the job that he wanted but himself! After successfully scaling Definity Health, Abir went on to do his MBA at Harvard University. His interest in founding and scaling companies of his own remained, and Abir went on to set up RedBrick Health, one of the first consumer engagement solutions for payers. After a few years at RedBrick Health, Abir founded his third company, Bloom Health, on the back of the Obamacare discussions that were emerging. Finally, Abir founded Gravie, where he is currently Executive Chairman and oversees the development of solutions that improve the way employers offer health benefits.


Discuss the payer adoption of digital health solutions at HealthXL Interactive

Discuss with peers like Abir Sen the adoption of digital health solutions by health plans. What are the value drivers and barriers for digital innovation in payer organizations? And what are the main opportunities in digital that have reimbursement potential?

Join us at HealthXL Interactive on September 2nd, 2020 here.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

The Power of Real-World Evidence in DTx-Pharma partnerships

3rd March @ 11:00 am EDT

Join our Digital Health Meeting as we discuss the power of RWE in DTx-Pharma partnerships. This is a great opportunity to connect with new people and listen to valuable insights from thought leaders in the industry. Apply promptly to avoid missing out.

Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE
Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx- Overview of the market and deals

8th March @ 10.30am EDT

Join our Digital Health Meeting as we discuss the DTx market and also the most remarkable investments and partnerships in the DTx industry in recent times. Listen, engage and enjoy.

Featuring
Dr Uzma Choudry
Dr Uzma Choudry
Venture Capital Investor, Octopus Ventures
Elan Tye
Elan Tye
Principal, JAZZ Venture Partners
Featuring
Dr Uzma Choudry
Dr Uzma Choudry
Venture Capital Investor, Octopus Ventures
Elan Tye
Elan Tye
Principal, JAZZ Venture Partners
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

How should we measure efficacy and safety of DTx products?

15th March @ 11:00am EDT

Join us as we discuss how efficacy and safety should be measured in DTx products. Apply now to interact with your peers and gain insight from thought leaders in the industry.

Featuring
Jessica Shull
Jessica Shull
European Lead, Digital Therapeutics Alliance
Jin Lee
Jin Lee
Director of Digital Health Product, Astellas
Featuring
Jessica Shull
Jessica Shull
European Lead, Digital Therapeutics Alliance
Jin Lee
Jin Lee
Director of Digital Health Product, Astellas
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Making sense of DTx partnerships

16th March @ 10:00am EDT

Join our Digital Health Meeting as we discuss making sense of DTx partnerships. Apply promptly to secure your place and connect with new people.

Featuring
Joris van Dam
Joris van Dam
Head of Digital Therapeutics, Novartis
Vijesh Unnikrishnan
Vijesh Unnikrishnan
Associate Principal, ZS
Featuring
Joris van Dam
Joris van Dam
Head of Digital Therapeutics, Novartis
Vijesh Unnikrishnan
Vijesh Unnikrishnan
Associate Principal, ZS

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

The Power of Real-World Evidence in DTx-Pharma partnerships

3rd March @ 11:00 am EDT

Join our Digital Health Meeting as we discuss the power of RWE in DTx-Pharma partnerships. This is a great opportunity to connect with new people and listen to valuable insights from thought leaders in the industry. Apply promptly to avoid missing out.

Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE
Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx- Overview of the market and deals

8th March @ 10.30am EDT

Join our Digital Health Meeting as we discuss the DTx market and also the most remarkable investments and partnerships in the DTx industry in recent times. Listen, engage and enjoy.

Featuring
Dr Uzma Choudry
Dr Uzma Choudry
Venture Capital Investor, Octopus Ventures
Elan Tye
Elan Tye
Principal, JAZZ Venture Partners
Featuring
Dr Uzma Choudry
Dr Uzma Choudry
Venture Capital Investor, Octopus Ventures
Elan Tye
Elan Tye
Principal, JAZZ Venture Partners
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation

Trial design to validate a digital health product

9th March @ 11:30am EDT

Join our Digital Health Meeting focused on the topic of Trial design to validate a digital health product. Apply now to get involved in the discussion, gain valuable insights and make new connections.

Featuring
Francesca Wuttke
Francesca Wuttke
Chief Digital Officer, Almirall
Quentin Le Masne
Quentin Le Masne
Director, Connected Health & Devices at Merck Group
Featuring
Francesca Wuttke
Francesca Wuttke
Chief Digital Officer, Almirall
Quentin Le Masne
Quentin Le Masne
Director, Connected Health & Devices at Merck Group
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

How should we measure efficacy and safety of DTx products?

15th March @ 11:00am EDT

Join us as we discuss how efficacy and safety should be measured in DTx products. Apply now to interact with your peers and gain insight from thought leaders in the industry.

Featuring
Jessica Shull
Jessica Shull
European Lead, Digital Therapeutics Alliance
Jin Lee
Jin Lee
Director of Digital Health Product, Astellas
Featuring
Jessica Shull
Jessica Shull
European Lead, Digital Therapeutics Alliance
Jin Lee
Jin Lee
Director of Digital Health Product, Astellas

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.